Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-β/Smad activity

World Journal of Gastroenterology

Volumn 16, Issue 26, 2010, Pages 3330-3334

  Zhou, Jun ^a   Zhong, De Wu ^a   Wang, Qun Wei ^a   Miao, Xiong Ying ^a   Xu, Xun Di ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Microtubules; Paclitaxel; Smad; Transforming growth factor

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; FIBRONECTIN; PACLITAXEL; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; LIVER FIBROSIS; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING;

EID: 77954559724     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i26.3330     Document Type: Article

References (19)

1. Li YR, Wei L. [Mechanism of transforming growth factor beta/Smad signaling and the relationship between its transduction and liver fibrosis] Zhonghua Ganzangbing Zazhi 2005; 13: 476-478
2. Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 2008; 14: 2100-2105
3. Parsons CJ, Takashima M, Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 2007; 22 Suppl 1: S79-S84
4. Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007; 56: 284-292
5. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006; 10: 76-99
6. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584
7. Dong C, Li Z, Alvarez R Jr, Feng XH, Goldschmidt-Clermont PJ. Microtubule binding to Smads may regulate TGF beta activity. Mol Cell 2000; 5: 27-34
8. Breitkopf K, Godoy P, Ciuclan L, Singer MV, Dooley S. TGF-beta/Smad signaling in the injured liver. Z Gastroenterol 2006; 44: 57-66
9. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7: d793-d807
10. Uemura M, Swenson ES, Gaça MD, Giordano FJ, Reiss M, Wells RG. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Biol Cell 2005; 16: 4214-4224
11. Tao YY, Cui HY, Liu CH. [Dynamic characteristics of SARA during liver fibrogenesis in rats] Zhonghua Ganzangbing Zazhi 2006; 14: 909-913
12. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002; 35: 49-61
13. Zhu S, Goldschmidt-Clermont PJ, Dong C. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability. Circ Res 2004; 94: 617-625
14. Liu X, Zhu S, Wang T, Hummers L, Wigley FM, Goldschmidt-Clermont PJ, Dong C. Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. PLoS Med 2005; 2: e354
15. Gelmon K. The taxoids: paclitaxel and docetaxel. Lancet 1994; 344: 1267-1272
16. Donaldson KL, Goolsby GL, Kiener PA, Wahl AF. Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ 1994; 5: 1041-1050
17. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667
18. Brahn E, Tang C, Banquerigo ML. Regression of collageninduced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum 1994; 37: 839-845
19. Cao L, Sun D, Cruz T, Moscarello MA, Ludwin SK, Whitaker JN. Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel. J Neuroimmunol 2000; 108: 103-111